E2F-1 is the prototype of a family of transcription factors playing a central role in the control of cell proliferation and apoptosis. E2F DNA binding activity is down-regulated during cellular dierentiation, which is correlated with cell division arrest. We report here that the expression of E2F-1 itself is down-regulated in the developing quail neural retina between embryonic days E8-E10. This event occurs just after the massive arrest of the quail neuroretina cell division (E7-E8). To gain further insight into the regulatory mechanisms monitoring E2F-1 expression in dierentiating neurons, we have cloned the quail E2F-1 promoter. In vivo DNA footprintings of this promoter have shown that a number of potential SP-1 and C/EBP response elements are constitutively occupied in the entire quail neuroretina of E5 and E14, whereas the two consensus palindromic E2F binding sites are only protected at E5. This suggests that these E2F elements participate in down-regulation of E2F-1 gene expression during avian neuroretina development. CAT reporter assays have shown that E2F-1 in association with its partner DP-1 transactivates its own promoter, whereas p105
Introduction
E2F-1 is the prototype of the E2F multigene family of transcription factors which is involved in the control of cell cycle progression and cell survival. Activation of E2F factors requires the heterodimerization with a member of the DP family. In contrast, when the phosphorylated form of the product of Retinoblastoma susceptibility gene, p105 Rb , or another member of this family, also known as pocket proteins, bind to the E2F/DP heterodimers, E2F transactivating activity is inhibited (reviewed by Slansky and Farnham, 1996; Sardet et al., 1997) . Interestingly, this association with Rb family also protects E2F factors from degradation by the ubiquitin-proteasome pathway (Hateboer et al., 1996; Hofman et al., 1996) . E2F activity is also negatively regulated through phosphorylation by cyclin/cyclin dependent kinase (cdk) complexes (Slansky and Farnham, 1996; Sardet et al., 1997; Dynlacht et al., 1997) .
E2F-1 overexpression may lead to deregulation of cell proliferation and/or apoptosis in cultured cells (Johnson et al., 1993; Shan and Lee, 1994; Xu et al., 1995) . Phillips et al. (1997) recently documented that the induction of apoptosis by E2F-1 is only dependent on retaining a DNA-binding region, whereas the entrance into the cell cycle additionally requires the transactivation. Interestingly, E2F-1 knock-out mice develop a broad and unusual spectrum of tumors with high metastatic potential, suggesting that E2F-1 may act as a tumor suppressor in vivo (Yamasaki et al., 1996; Field et al., 1996) . This re¯ects the dual nature of E2F-response sites, ie activation or repression of transcription depending on the promoter context. E2F response elements are found in a number of cellular and viral promoters (Slansky and Farnham, 1996) . In particular, E2F-1 controls the expression of genes involved in G1 and S phase progression of the cell cycle, such as genes encoding B-myb, cyclin E, E2F-1, thymidine kinase, dihydrofolate reductase and DNA polymerase a (Slansky and Farnham, 1996) . In addition, although p34 cdc2 lacks a clear role in the G1 to S transition, cdc2 gene expression is also induced at the G1/S boundary, via, at least in part, E2F binding sites (Dalton, 1992; North et al., 1996) existing in the promoter of cdc2.
We are interested in studying cellular dierentiation in the central nervous system; as an experimental model, we use embryonic quail neural retina. Indeed the control of cell proliferation in dierentiating neurons may involve speci®c mechanisms, compared with other cell types (Altschuler et al., 1991) . We have previously shown that cdc2 transcription is downregulated in the developing quail neuroretina, at least in part due to the inactivation of E2F-1 activity by p105
To study the molecular mechanisms controlling expression of E2F-1 in embryonic retina, we have cloned and sequenced the entire quail E2F-1 gene, including the 5' proximal promoter region. In vivo genomic footprinting experiments performed in an entire quail neuroretina at E5 and E14 stages show that some C/EBP and SP-1 binding sites are likely involved in E2F-1 gene expression, as well as E2F binding sites located around the two transcription start sites. We report here that the E2F-1 promoter is only activated at the G1/S transition. According to in vivo genomic footprinting and transfection experiments, this periodicity is probably due to the interaction of an Rb family member on the E2F binding sites. We have also shown that E2F-1 cotransfected with DP-1 activates its own expression in quail QT6 cells via two pathways: one pathway dependent and the other independent of consensus E2F binding sites.
Results

E2F-1 is gradually down-regulated in the developing quail neural retina
Most cells in the developing retina cease to proliferate between embryonic days E7-E8, which is correlated with the down-regulation of cdc2 gene expression. During this period, the hypophosphorylated form of p105
Rb accumulates, suggesting that E2F-1 is inactivated in dierentiating retinoblasts (North et al., 1996) . The results depicted in Figure 1 indicate that amounts of E2F-1 protein ( Figure 1a ) and transcript ( Figure 1b) Figure 1 E2F-1 expression in the developing quail neuroretina. (a) Top: Western blot analysis. Equal amounts of E5-11 neuroretina protein extracts (10 mg) were loaded on a 10% polyacrylamide gel. After electrophoresis, proteins were transferred onto a nitrocellulose membrane. The membrane was probed with a monoclonal anti-human E2F-1 antibody. E2F-1 protein was revealed using the ECL detection kit (Amersham). Bottom: Coomassie blue staining for calibration of amount of protein loaded. (b) Northern blot analysis. Each lane was loaded with 10 mg of total RNA from E5 to E17 (hatching) embryonic neuroretina. Top: Northern blot was probed with agarose gelpuri®ed chick E2F-1 cDNA radiolabeled by nick translation. Bottom: glyceraldehyde-3-phosphate deshydrogenase (GAPDH) calibration of the same blot gradually decrease between E8 and E10 with the same time course. This result suggests that, in addition to the E2F-1 post-translational inactivation during neuroretina development, transcription of E2F-1 gene itself is down-regulated 1 to 2 days later.
Organization of quail E2F-1 gene
In order to investigate how the E2F-1 gene expression is controlled in the developing retina, we cloned the quail E2F-1 gene by screening a quail genomic library (see Materials and methods for details), using chick E2F-1 cDNA as a probe (Pasteau et al., 1995) . Organization of the quail E2F-1 gene was determined by comparing cDNA (Pasteau et al., 1995) and genomic sequences (Figure 2a) . The 4 kb E2F-1 gene contains seven exons and six introns, the same as the human E2F-1 gene (Neuman et al., 1996) . The bHLH domain is encoded by exons 2 and 3, the leucine zipper domain by exon 4 and the p105
Rb binding domain by exon 7 (Figure 2b ). The¯anking sequences of introns are also conserved between human and quail E2F-1 genes, in particular the non-consensus 5' and 3' splice sites of intron 4 (Neuman et al., 1996) .
DNA sequencing and primer extension experiments have revealed two transcription start sites (Figure 3a) . The sequence analysis of the proximal E2F-1 promoter shows that four potential E2F response elements are located close to the transcription start sites; six SP-1 binding sites and four C/EBP boxes are found upstream of the E2F sites (Figure 3b ). Comparison with human and rat E2F-1 promoters shows that E2F sites and one C/EBP box are strictly conserved, whereas one SP-1 site and a second C/EBP box are partially conserved (Figure 3c ). Conservation of these elements throughout evolution suggests that they may control E2F-1 promoter activity in all three species.
In vivo genomic footprinting of the quail E2F-1 promoter To investigate whether these putative sites are likely to be involved in the regulation of E2F-1 gene expression during quail neuroretina development, we carried out several in vivo genomic footprinting experiments in the whole quail neuroretina of E5 and E14 stages. These stages correspond respectively to the active phase of proliferation, where E2F-1 gene is strongly transcribed, and the quiescent state, where E2F-1 gene expression is undetectable (Figure 1 ; Espanel et al., 1997) . At ®rst we performed these experiments upon the region from 7165 to 717 to look at C/EBP and SP-1 site occupancy. As, to date, no one had performed in vivo genomic footprinting experiments on entire tissues, we Figure 3 Identi®cation of quail genomic E2F-1 5'¯anking sequence. (a) Mapping of the 5' end of quail E2F-1 transcript by primer extension. Reaction was carried out using 5 mg mRNA from embryonic neuroretina (E7). Reaction products were run on a 6% polyacrylamide-7M urea sequencing gel and autoradiographed (lane E, arrows). Sequence (Sanger) of the corresponding genomic region, using the same primer (lanes GATC). Highest arrow shows the major transcription start site. (b) Sequence of the proximal promoter region of quail E2F-1 gene. Position of the two transcription start sites is indicated (tilted arrows). A number of potential binding sites to known transcription factors are boxed. Black triangles indicate positions of deletion used in Figure 7 . Position of relevant restriction site is indicated. (c) Multiple alignment of promoter regions of E2F-1 genes from quail, mouse (Hsiao et al., 1994) and human (Johnson et al., 1994) . Identical nucleotides are shaded. Potential response elements to transcription factors are boxed. Black circles show position of transcription start sites E2F-1 expression in avian cells X Espanel et al also used quail ®broblasts in culture as a control (QT6 cells). As shown in Figure 4 , there is no dierence between QT6 cells and E5 neuroretina in the pattern of protection from guanine methylation by dimethyl sulfate (DMS). This result demonstrates that in vivo genomic footprinting experiments on entire neuroretina are reliable. The ®rst three potential C/EBP boxes are occupied, since their two guanines are slightly protected. The SP-1 site located at position 7126 is also protected on its guanines 7123, 7122 and 7120. In contrast, two SP-1 sites positioned at 741 and 7138 exhibit a hypermethylation on guanines 738 and 7135, suggesting that these bases are more accessible to DMS due to protein binding on the other strand or in their vicinities. Since no dierence in the pattern of protection is noticeable between E5 and E14, these C/EBP and SP-1 elements are likely constitutively occupied during the quail neuroretina development. Therefore, this suggests that these sites are required rather for E2F-1 basal transcription than for E2F-1 down-regulation during development. However, these experiments having been performed only on the non-coding strand (antisense), we can not exclude the possibility that the patterns of protection of these sites on the coding strand (sense) are slightly dierent between E5 and E14. Moreover, it is also possible that dierent complexes bind to these elements with the same footprint, and activate or repress E2F-1 gene expression, as has been shown for the cyclin A promoter (Nakamura et al., 1995) .
We focused our experiments on E2F responsive elements because they are the most conserved sites on the E2F-1 promoter throughout evolution. As shown in Figure 5 , these two palindromic E2F binding sites are protected on both strands in E5 neuroretina and QT6 cells. It is worth noting that the patterns of guanine protection are not exactly the same between E5 neuroretina and QT6 cells, suggesting that, probably, complexes that bind to E2F responsive elements are slightly dierent. The hypermethylation of adenine bases that are observed on the sense strand, only for neuroretina DNA samples ( Figure 5a , panel S), is likely due to the quality of DNA because the in vitro DNA sample from neuroretina possesses also this pattern. This methylation of adenine bases is not unexpected because DMS can also methylate adenine on N-3 which protrudes into the minor groove of DNA. Figure 5a shows above all that, in contrast to E5, the E2F responsive elements are not protected at E14, suggesting that these sites are likely involved in the regulation of E2F-1 gene expression during neuroretina development.
Regulation of E2F-1 promoter activity during the cell cycle
The occupation of these E2F responsive elements strongly suggests that the quail E2F-1 promoter activity is regulated during the cell cycle. To investigate this hypothesis, a 622 base-pair restriction fragment containing the majority of the proximal E2F-1 promoter was cloned upstream of the CAT reporter gene (proE2F-CAT) and stably transfected into NIH3T3 cells. NIH3T3 cells were used because they are amenable to ecient synchronization. To avoid position eects due to the random integration of the proE2F-CAT construct, more than 200 clones were pooled together. After synchronization in G0/G1 phase by serum starvation, these clones were induced to reenter the cell cycle by serum readdition. During this induction, CAT transcript level was determined by RT ± PCR which gave a better estimation of transcription activity than classical CAT assays. Indeed, due to the high stability of the CAT protein, CAT enzymatic activity remained constitutively high in those stably transfected cells, being poorly related to variations of E2F-1 promoter activity (not shown). As shown in Figure 6 , CAT transcript level is almost undetectable when the cells are quiescent (G0/G1 phase), whereas 12 h following the addition of serum, which corresponds to the G1/S transition, the CAT transcript level peaks. Therefore, the quail E2F-1 transcription is also strongly activated at the G1/S transition, as has been shown for the human and murine homologs of the E2F-1 gene (Johnson et al. 1994; Hsiao 1994; Neuman et al., 1996) . This result also indicates that the proE2F-CAT construct possesses most, if not all, regulatory elements allowing regulation of E2F-1 transcription in a cell cycle-dependent manner.
Functional analysis of the quail E2F-1 promoter region
To identify which regions are involved in the control of E2F-1 gene expression, we generated several deletion mutants from the proE2F-CAT construct. These dierent constructs were transiently transfected into exponentially growing QT6 cells. As shown in Figure 7 , deletion of the 7244 to 7131 region with respect to the main transcription start site (D3 deletion), leads to a marked decrease of E2F-1 promoter activity (90 ± 30% of proE2F-CAT activity). This suggests that this region contains the major elements required for an ecient promoter activity. Interestingly, the D1 mutant, lacking the 7602 to 7454 region exhibits 60% of the maximal promoter activity, whereas the D2 deletion (7454 to 
Taken together these latest results suggest that the 7602 to 7454 region may be recognized by transactivators, whereas the 7454 to 7244 region may negatively control E2F-1 promoter activity. In exponentially growing QT6 cells, deletion of the E2F binding sites (proE2F(D)-CAT) seems to have little eect on the basal activity of the E2F-1 promoter, suggesting that these sites, despite their remarkable conservation during evolution, are not required for E2F-1 transcription. This result also suggests that the two major transcription start sites of E2F-1 promoter, which are located within E2F binding sites may be dispensable. Indeed other cryptic initiation sites located in the vector itself are probably used in the proE2F(D)CAT construct, which remains transcriptionally active although lacking the region encompassing the two E2F binding sites.
Since E2F-1 transcription is activated in a cell cycledependent manner, we re-investigated the possible role of these E2F binding sites in cells synchronized in G0/ G1 phase, as compared with proliferating cells. To this end, proE2F-CAT and proE2F(D)-CAT constructs were transiently transfected into QM7 cells, a subclone of QT6 cells that exhibits massive growth arrest in G0 upon serum starvation (Antin and Ordahl, 1991) . Figure 8a shows that proE2F-CAT transcription is inhibited in G0-arrested cells, as expected (see Figure  6 ). Interestingly, this down-regulation is no longer observed when the E2F sites are deleted, indicating that these E2F responsive elements seem to be required for E2F-1 transcriptional inhibition in G0/G1 phase. This negative eect could explain why the proE2F(D)-CAT plasmid produces a stronger CAT activity than the proE2F-CAT construct. Furthermore, as shown in Figure 8c , p105 Rb inhibits E2F-1 transcription in proliferating QT6 cells, only when the E2F binding sites are present. Moreover, the proE2FD4construct, which possesses only the E2F-response elements is still sensitive to inhibition by p105
Rb (data not shown). Taken together our results suggest that E2F/Rb complexes may actively repress E2F-1 transcription in G0/G1 phase when the complex is bound to the E2F response elements.
In addition, as shown in Figure 9 , the E2F binding sites can also mediate positive transactivation. Indeed, when overexpressed in QT6 cells, E2F-1 itself was found to transactivate its own promoter, this eect being enhanced in the presence of its partner DP-1. This eect is observed with the D4 deletion of E2F-1 promoter, which contains only the E2F-response elements (data not shown). Interestingly, the E2F-1 overexpression also partly releases the inhibition of E2F-1 promoter mediated by p105
Rb (not shown). Taken together, these results indicate that the transactivation by E2F-1/DP-1 complex is mainly Figure 7 Activity of various deletion mutants of quail E2F-1 promoter. Quail E2F-1 promoter-CAT reporter constructs were cotransfected into QT6 ®broblasts with pb-actin-lacZ for calibration of transfection eciency. CAT assays were performed as described in Materials and methods. Each experiment was performed in duplicate. Position of the 5' ends of the deletion mutants are shown according to the +1 reference (Figure 3b ). Relative CAT amounts are indicated on the right Figure 8 p105
Rb inhibits E2F-1 transcription via E2F response elements covering the transcription start site. Histograms show relative CAT activity. (a) The E2F binding sites mediate inhibition of E2F-1 transcription in G0/G1. CAT assays were carried out on QM7 cells either synchronized in G0 (0.5% serum) or exponentially growing (15% serum). CAT constructs (1 mg) were cotransfected with pb-actin-lacZ for calibration of transfection eciency. proE2F(D)-CAT is a deletion mutant lacking the E2F response elements. ClaCAT and p0CAT are used as positive and negative control respectively; ClaCAT harbors the SV40 promoter, p0CAT lacks the entire E2F promoter. See Materials and methods for details. Interestingly, Figure 9 also shows that E2F-1/DP-1 heterodimer is still able to slightly transactivate a promoter lacking the E2F response elements, this eect being repressed by p105 Rb (not shown). This suggests that, in addition to the identi®ed E2F binding sites, other regions of the E2F-1 promoter may mediate, directly or indirectly, a part of the E2F-1 eect on its own transcription.
Discussion
In adults, most mature neurons are unable to reenter the cell cycle. Speci®c mechanisms probably exist in these cells to prevent activation of the cell cycle machinery even in the presence of external stimulatory factors. Therefore, neurons may possess speci®c means of permanently inhibiting the expression of cdc2 and other genes involved in cell cycle progression. We have previously reported that cdc2 gene expression was down-regulated in the developing retina, this downregulation being at least in part due to the inhibitory eect of p105
Rb on cdc2 promoter activity (North et al., 1996; Espanel et al., 1997) . We report here the downregulation of E2F-1 gene expression itself in the developing retina. Since E2F-1 is a transactivator of the cdc2 promoter (North et al., 1996; Dalton, 1992) , the disappearance of E2F-1 may participate in the de®nitive extinction of cdc2 expression in differentiating retinoblasts. Moreover, targeted overexpression of E2F-1 and DP-1 in the drosophila eye results in profound disorganization of photoreceptor layers, suggesting that the down-regulation of E2F activity is a necessary event in the developing retina (Du et al., 1996) .
To gain insight into regulatory mechanisms monitoring E2F-1 gene expression in avian cells, we cloned and sequenced the quail E2F-1 gene. Organization of the avian gene is very similar to the human gene (Neuman et al., 1996) , indicating that this gene has been very well conserved throughout evolution.
Analysis of the sequence of the promoter region also shows a good conservation between mammalian and avian species, especially near the two double E2F binding sites found as tandem repeats close to the transcription start site (Johnson et al., 1994; Hsiao et al., 1994; Neuman et al., 1996) . Analysis of E2F-1 gene expression during the cell cycle has shown that this gene is only activated at the G1/S transition, like its mammalian homologs (Johnson et al. 1994; Hsiao, 1994; Neuman et al., 1996) . This suggests that regulatory mechanisms of E2F-1 expression have been conserved among these species at least in part. To further study the role of these potential E2F binding sites in the quail E2F-1 promoter during development, we carried out a series of in vivo footprinting experiments directly on freshly dissected entire neuroretina. Our results indicate that the ®rst three C/EBP boxes and three SP-1 motifs are occupied in E5 neuroretina, as well as in E14 neuroretina. In contrast, E2F binding sites are only protected at E5. These results strongly suggest that the E2F sites participate in the down-regulation of the E2F-1 promoter activity during the development of the neuroretina. In contrast the other elements, i.e.: SP-1 and C/EBP boxes, are rather involved in the basal activation of E2F-1 promoter.
The deletion of E2F responsive elements on the E2F-1 promoter prevents the inactivation of the avian and mammalian promoter in G0/G1 phase, suggesting that these motifs are necessary for the down-regulation of E2F-1 gene expression in this particular phase of the cell cycle (Johnson et al., 1994; Neuman et al., 1996; Hsiao et al., 1994) . This inhibition is probably mediated by p105
Rb or a related protein, as shown by we and others (Figure 8c ; Johnson et al., 1994; Neuman et al., 1994; Hsiao et al., 1994; Johnson, 1995) . This eect is also observed in exponentially growing QM7 cells in which CAT assays have shown that a deletion of the E2F responsive element results in an activation of the E2F-1 promoter (Figure 8a ). Similar promoter activity increase has also been reported in human ®broblasts synchronized in G0, but not in the other phases of the cell cycle, suggesting that E2F sites are speci®cally bound to an inhibitory complex in G0 (Johnson et al., 1994) . However, deletion of the E2F response elements has little eect on E2F-1 promoter basal activity in non-synchronized QT6 cells. The molecular basis of this apparent discrepancy between QM7 and QT6 cells is unclear. Contrary to QT6 cells, QM7 cells are still able to stop proliferating and to dierentiate into muscular cells under special conditions (Antin et al., 1991) . So, one possible explanation could be that these two cellular lines do not possess the same ratio of inhibitory factors that interact on these E2F binding sites, e.g. p105 Rb / E2F, p130/E2F and p107/E2F. Several studies have shown that the ratio and the succession of these complexes are very important to trigger cell cycle arrest and to commit cells toward dierentiation (Tommasi and Pfeifer, 1995; Corbeil et al., 1995; Johnson, 1995) . Taken together our data suggest that the down regulation of E2F-1 gene expression during the development of the quail neuroretina is due to the binding of E2F/DP/pocket protein complexes on the E2F binding sites. The precise nature of these complexes is unknown. However we have shown by 
Rb /E2F-1 complex only appears between E6-E7 when most of neuroretina cells stop dividing. Whereas the p130/E2F-4 complex accumulates from E8, precisely when E2F-1 gene expression is shutting down. This suggests that this p130/E2F-4 complex could be directly implicated in the de®nitive inhibition of E2F-1 gene expression and allow neuronal terminal dierentiation. As in vivo genomic footprinting experiments performed have shown, E2F binding sites are no longer occupied at E14. This implies that, after the inhibition of E2F-1 gene expression by members of the Rb family, other mechanisms, such as DNA methylation, possibly take place to keep the E2F-1 promoter inactivated.
Our cotransfection experiments have clearly shown that these E2F responsive elements also mediate E2F-1 transactivation of its own promoter. This transactivation may be due, at least in part, to displacement of a repressive E2F/Rb complex, free E2F and E2F/Rb binding to the same response element being mutually exclusive. The fact that E2F partly alleviates the inhibiting eect of p105
Rb on E2F-1 promoter activity (results not shown) supports this idea. Interestingly, E2F-1 overexpression still results in a partial activation of its own promoter even when the E2F binding sites have been deleted. This suggests that indirect mechanisms or cryptic E2F binding sites are involved in this transactivation. A similar observation has been made with the murine promoter (Hsiao et al., 1994 ). Azizkhan's laboratory has shown that E2F-1 can transactivate the hamster dihydrofolate reductase (DHFR) promoter via its SP-1 site, when E2F-1 can directly interact with SP-1 factor (Lin et al., 1996) . As the quail E2F-1 promoter possesses SP-1 sites, some of which are occupied in vivo, one might argue that the E2F-1 transactivation on the E2F site deleted promoter is due to the E2F-1/SP-1 complex bound on SP-1 sites. This result together with progressive deletion and footprinting experiments suggests that other regions of the promoter located upstream of the E2F binding sites are likely to participate in the regulation of E2F-1 transcription. Precise identi®cation of these complexes may also help to understand how cell cycle control is coupled to cellular dierentiation in nerve cells.
Materials and methods
Animal strain
Quail (Coturnix coturnix japonica) fertile eggs were incubated at 378C in humidi®ed atmosphere and submitted to periodic rocking motion.
Cell culture QT6, QM7, NIH3T3 and HeLa cells were grown in Dulbecco's modi®ed Eagle's medium (Gibco BRL). Serum concentrations were as follows: QT6, 5% fetal calf serum (FCS)+1% chicken serum; QM7, either 15% (proliferation) or 0.5% (dierentiation); NIH3T3, either 10% (proliferation) or 0.5% (G1 arrest); HeLa, 10% FCS.
Plasmids
The NotI ± BssHII fragment (622 bp) of quail E2F-1 gene was treated with Klenow and was subloned into p0CAT (previously cut by XbaI and polished with Klenow) to check for its promoter activity. This construct was named proE2F-CAT. To obtain p0CAT, the reporter plasmid pBLCAT2 was cut by BamHI and BglII to remove the thymidine kinase (TK) promoter. The plasmid ends were ®lled in with Klenow and religated. Deletion mutants were obtained by using several restriction sites inside the promoter.
pb-actin-lacZ was obtained by replacing the SV40 promoter by the rat b-actin promoter in the vector pCH110 (Promega). Plasmids pLTR-E2F and pLTR-DP1: E 2 F-1 and DP-1 open reading frames were cloned in the SmaI sites of pLTR. pLTR was obtained by removing the c-jun cDNA from pLTR-c-jun (MeÂ tivier et al., 1993) .
pECE-Dp34-HA is a gift from Dr Hamel, it encodes a constitutively active form of human p105
Rb (Hamel et al., 1992) . pSV40 was obtained by removing the Rb open reading frame from pECE-Dp34-HA. E2-CAT was obtained from Nick Jones (ICRF, London). claCAT was obtained by ligation at EcoRi ± XbaI sites of cla 12 vector (Hugues et al., 1987) of the EcoRI ± XbaI fragment of pCAT vector (Promega). This fragment possesses the CAT open reading frame under the control of SV40 promoter. Blunting reactions were performed using the DNA blunting kit (Amersham).
Western blots SDS ± PAGE was performed following the standard technique of Laemmli (1970) with 8% polyacrylamide gels. After transfer onto nitrocellulose (Schleicher and Schuell) and blocking with 5% low-fat dried milk, the blot was incubated overnight at 48C with anti-human E2F-1 at 1/1000 dilution (C20, rabbit polyclonal, Santa Cruz). After incubation for 1 h with anti-rabbit peroxidase-coupled secondary antibody at room temperature, detection by chemi-luminescence was performed following the standard protocol described in ECL user's guide (Amersham).
RNA puri®cation and Northern blots
Five to 10 neuroretina were dissected daily from E5-14 quail embryos. Cells were homogenized in 2 ml of guanidium isothiocyanate buer (5 M, guanidium isothiocyanate; 10 mM EDTA; 50 mM Tris, pH: 7.5; 8% bmercaptoethanol). Each lysate was then mixed with 16 ml of a cold 4 M LiCl solution (48C) and kept overnight on ice. RNA was pelleted by centrifugation (30 min, 10 000 r.p.m. in a JS 13 Beckman rotor). RNA pellet was resuspended in a phenol-saturated saline buer (10 mM Tris, pH: 7.5; 1 mM EDTA, pH: 8; 0.1% SDS; 5% Trissaturated phenol). After phenol/chloroform extraction, RNA was precipitated with ethanol and resuspended in sterile H 2 O. Northern blots were performed as previously described (Gillet et al., 1993) .
Promoter cloning and sequencing
The quail genomic library was constructed from a partial Sau3A digest following the standard protocol of Kaiser and Murray (1985) . The library was screened with the chick E2F-1 cDNA (Pasteau et al., 1995) using standard protocols (Sambrook et al., 1989) . The radiolabelled XE1 primer (5'-CGGGCTGTCCCGCGCTCCGGC-3') was used as a probe. Phages which possessed the 5' region of E2F-1 gene were selected. DNA of these selected phage was puri®ed as described (Gillet et al., 1993) . BamHI digestion of one selected phage gave us three fragments which were cloned in pBSK. Using Sanger's method, we have sequenced the whole E2F-1 gene with a part of 5' and 3' anking region. The full gene was contained in two clones of 3 and 3.2 Kb.
E2F-1 expression in avian cells
X Espanel et al
Primer extension
Poly(A) + RNA was prepared from QT6 cells as described (Gillet et al., 1993) . 5 mg poly(A) + RNA were annealed with the XE1 primer in 26 buer of M-MLV RT (Gibco-BRL) for 1 h at 708C. Elongation reaction was performed at 428C for 1 h in 16 M-MLV RT buer with 0.5 mM (each) dNTP, 10 mM DTT, 40 units RNAse inhibitor and 50 units reverse transcriptase (M-MLV of Gibco-BRL). Reverse transcriptase was heat inactivated at 658C for 10 min and 100 ng of RNAase A was added for 10 min at 378C. After phenol/chloroform extraction and ethanol precipitation, reaction products were run on an 8% polyacrylamide sequencing gel.
Genomic footprinting
Freshly dissected embryonic neuroretina of 5 and 14 days or QT6 cells were treated with 0.2% dimethyl sulfate (DMS; Aldrich) in culture medium or PBS buered with 20 mM HEPES pH: 7.3 for 5 min at room temperature. Then DMS was removed and samples were washed three times in PBS with 2%b-mercaptoethanol and incubated in lysis buer (50 mM Tris pH: 8, 20 mM EDTA, 1%SDS, 2%b-mercaptoethanol) for 5 ± 10 min at room temperature. After three phenol/chloroform extractions at 48C, DNA was precipitated in 2 M ammonium acetate with 2.5 volumes of ethanol. DNA was cleaved by 10% piperidine at 958C for 30 min. After cleavage, piperidine was removed by three adsorptions on plastic walls of cold Eppendorf tubes, two ethanol precipitations and one lyophilization step. 2 mg of cleaved DNA were ampli®ed by ligationmediated PCR (LMPCR, see reference Espinas et al., 1994) in presence of 10% DMSO. Ampli®ed fragments were separated on a 6% polyacrylamide-7M urea sequencing gel in TBE (Tris-borate-EDTA). The third primer from the appropriate quail E2F-1 primer sets was labeled with g 32 P-ATP by T4 polynucleotide kinase (Promega). In vitro control was performed with DNA isolated from QT6 cells or from E7 neuroretina. This DNA was methylated in vitro at 208C for 4 min in DMS buer (50 mM sodium cacodylate pH: 8, 1 mM EDTA, 0.5% DMS). The reaction was stopped by 0.3 M sodium acetate and 20% bmercaptoethanol.
The following primer set was used to analyse sense quail E2F-1 promoter: SE2F1A: 5'-CCGAGACGCCTCCC-GATTGG-3'; SE2F1B: 5'-CAGCTCGGCGGTTCTGATT-GGC-3'; SE2F1C: 5'-GGTTCTGATTGGCCGCCTGTCA-GC-3'.
The following primer set was used to analyse antisense quail E2F-1 promoter: ASE2F1A: 5'-GATCCGCGGGG-CCGTTCC-3'; ASE2F1B: 5'-CGTTCCCCAGGTCGTT-CCG-3'; ASE2F1C: 5'-CCAGGTCGTTCCGGGCCG-TTCC-3'.
The ligated Linker is the canonical linker used for this type of experiment 5'-GCGGTGACCCGAGAGATCT-GAATTC-3' annealed with 5'-GAATTCAGATC-3'.
RT ± PCR
1 mg of total RNA was treated by 1 unit of DNase I/RNase free at 378C for 1 h. DNase was inactivated at 658C for 15 min. RNA was annealed with random hexanucleotides (1.25 mM) in M-MLV RT buer (Gibco ± BRL) plus 250 ng dNTP (each), 10 mM DTT and 200 units of M-MLV RT (Gibco ± BRL). This mix was incubated 1 h at 378C. RT was then heat inactivated for 10 min at 658C. An aliquot (1/20) of the reaction was used for PCR which was performed in Taq buer (Appligene) with 25 mM dNTP, 10 ng primers and 0.25 units Taq polymerase (Appligene). To distinguish genomic and RNA ampli®cations, a control was made without RT enzyme. Primers used for CAT ampli®cation: CAT 5' primer: 5'-GAGATTTTCAGGAGC-TAAGGAAG-3' and CAT AS1 primer: 5'-ACGTTT-CAGTTTGCTCATGG-3'. Primers used for b-actin ampli®cation: BA sens: 5'-GACAGGATGCAGAAGGA-GAT-3' and BA antisens: 5'-TTGCTGATCCA-CATCTGCTG-3'.
Cell cycle analysis
For FACS analyses, cells were trypsinized, washed in PBS and ®xed with three volumes of cold ethanol (7208C). After extensive washes, cells were treated by RNase A (1 mg/ml) for 30 min before propidium iodide addition (10 mg/ml). Analyses were performed on a BectonDickinson cyto¯uorimeter (FACS-SCAN) and results analysed with ModFitLT software.
Transfections and CAT assay
Transfection assays were carried out using the calcium phosphate precipitation method: puri®ed plasmid DNA in Tris EDTA buer (pH: 7.5) were mixed with an equal volume of HEPES buer (NaCl 280 mM, HEPES 50 mM, Na 2 HPO 4 1.5 mM, pH: 7.2), CaCl 2 (2 M) was added to a ®nal concentration of 150 mM. Samples were incubated at room temperature for 30 min and then dropped in 60 mm culture dishes containing 3610 5 cells. The medium was changed 18 h later and cells were further incubated for 36 h at 378C before lysis in CAT-ELISA lysis buer (Boehringer). CAT-ELISA assays were carried out with 200 ml of cell extract and b-galactosidase assays were carried out with 45 ml of the same extract, as a control for transfection eciency (Herbomel et al., 1984) . Each assay was carried out in duplicate. In each assay, 0.5 ± 1 mg of pb-actin-lacZ were cotransfected with the reporter plasmid. CAT activity was calibrated against b-galactosidase activity as described (Herbomel et al., 1984) .
